Dr. Richard T. Penson, Dr. Bradley J. Monk, and Dr. Krishnansu S. Tewari discuss the evolution of cervical cancer treatment over the past five years.
By Peter J. Sciavolino, PhD
Advertisement
Articles by By Peter J. Sciavolino, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Durvalumab Plus Enfortumab Vedotin Improves Survival in Cisplatin-Ineligible MIBC
2
Tovecimig Plus Paclitaxel Improves ORR vs Paclitaxel Alone in Biliary Tract Cancer
3
Pembrolizumab Plus Radiation Fails to Improve Recurrence-Free Survival in Early-Stage High-Intermediate–Risk dMMR Endometrial Cancer
4
LK101 Plus Tislelizumab Elicits Responses in Advanced NSCLC
5